These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37245474)

  • 61. Evaluation of Blood Intercellular Adhesion Molecule-1 (ICAM-1) Level in Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis.
    Imani MM; Sadeghi M; Gholamipour MA; Brühl AB; Sadeghi-Bahmani D; Brand S
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295659
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Soluble P-selectin levels in patients with obstructive sleep apnea: a systematic review and meta-analysis.
    Zhu D; Xu Z; Liu T; Li Y
    Eur Arch Otorhinolaryngol; 2021 Dec; 278(12):4633-4644. PubMed ID: 33950356
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections.
    Krut JJ; Zetterberg H; Blennow K; Cinque P; Hagberg L; Price RW; Studahl M; Gisslén M
    J Neurol; 2013 Feb; 260(2):620-6. PubMed ID: 23052602
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease.
    Liguori C; Romigi A; Nuccetelli M; Zannino S; Sancesario G; Martorana A; Albanese M; Mercuri NB; Izzi F; Bernardini S; Nitti A; Sancesario GM; Sica F; Marciani MG; Placidi F
    JAMA Neurol; 2014 Dec; 71(12):1498-505. PubMed ID: 25322206
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical indications for analysis of Alzheimer's disease CSF biomarkers.
    Engelborghs S
    Rev Neurol (Paris); 2013 Oct; 169(10):709-14. PubMed ID: 24016466
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease.
    Rosén C; Andreasson U; Mattsson N; Marcusson J; Minthon L; Andreasen N; Blennow K; Zetterberg H
    Neuromolecular Med; 2012 Mar; 14(1):65-73. PubMed ID: 22350541
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Soluble TREM2 in body fluid in Alzheimer's disease and Parkinson's disease.
    Gu L; Shu H; Wang Y
    Neurol Sci; 2023 Aug; 44(8):2743-2751. PubMed ID: 36913148
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    Ma YH; Wang YY; Tan L; Xu W; Shen XN; Wang HF; Hou XH; Cao XP; Bi YL; Dong Q; Yang JL; Yu JT
    J Alzheimers Dis; 2021; 81(1):263-272. PubMed ID: 33749650
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Progression of Subjective Cognitive Decline to MCI or Dementia in Relation to Biomarkers for Alzheimer Disease: A Meta-analysis.
    Rostamzadeh A; Bohr L; Wagner M; Baethge C; Jessen F
    Neurology; 2022 Oct; 99(17):e1866-e1874. PubMed ID: 36028322
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Event-related Potentials Improve the Efficiency of Cerebrospinal Fluid Biomarkers for Differential Diagnosis of Alzheimer's Disease.
    Babić Leko M; Krbot Skorić M; Klepac N; Borovečki F; Langer Horvat L; Vogrinc Ž; Sonicki Z; Hof PR; Šimić G
    Curr Alzheimer Res; 2018; 15(13):1244-1260. PubMed ID: 30207231
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cognitive Dispersion Is Not Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Results from the European Prevention of Alzheimer's Dementia (EPAD) v500.0 Cohort.
    Watermeyer T; Marroig A; Ritchie CW; Ritchie K; Blennow K; Muniz-Terrera G;
    J Alzheimers Dis; 2020; 78(1):185-194. PubMed ID: 32955462
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Biomarkers in the cerebrospinal fluid of patients with mild cognitive impairment: a meta-analysis of their predictive capacity for the diagnosis of Alzheimer's disease].
    Monge-Argilés JA; Sánchez-Payá J; Muñoz-Ruiz C; Pampliega-Pérez A; Montoya-Gutiérrez J; Leiva-Santana C
    Rev Neurol; 2010 Feb 16-28; 50(4):193-200. PubMed ID: 20198590
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly. A Longitudinal Study.
    Sharma RA; Varga AW; Bubu OM; Pirraglia E; Kam K; Parekh A; Wohlleber M; Miller MD; Andrade A; Lewis C; Tweardy S; Buj M; Yau PL; Sadda R; Mosconi L; Li Y; Butler T; Glodzik L; Fieremans E; Babb JS; Blennow K; Zetterberg H; Lu SE; Badia SG; Romero S; Rosenzweig I; Gosselin N; Jean-Louis G; Rapoport DM; de Leon MJ; Ayappa I; Osorio RS
    Am J Respir Crit Care Med; 2018 Apr; 197(7):933-943. PubMed ID: 29125327
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    Li QX; Villemagne VL; Doecke JD; Rembach A; Sarros S; Varghese S; McGlade A; Laughton KM; Pertile KK; Fowler CJ; Rumble RL; Trounson BO; Taddei K; Rainey-Smith SR; Laws SM; Robertson JS; Evered LA; Silbert B; Ellis KA; Rowe CC; Macaulay SL; Darby D; Martins RN; Ames D; Masters CL; Collins S;
    J Alzheimers Dis; 2015; 48(1):175-87. PubMed ID: 26401938
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.
    Renard D; Wacongne A; Ayrignac X; Charif M; Fourcade G; Azakri S; Le Floch A; Bouly S; Marelli C; Arquizan C; Hirtz C; Gabelle A; Thouvenot E; Lehmann S
    J Alzheimers Dis; 2016; 50(3):759-764. PubMed ID: 26757185
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.
    Riemenschneider M; Lautenschlager N; Wagenpfeil S; Diehl J; Drzezga A; Kurz A
    Arch Neurol; 2002 Nov; 59(11):1729-34. PubMed ID: 12433260
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differential associations of clinical features with cerebrospinal fluid biomarkers in dementia with Lewy bodies and Alzheimer's disease.
    de Oliveira FF; Miraldo MC; de Castro-Neto EF; de Almeida SS; Matas SLA; Bertolucci PHF; Naffah-Mazzacoratti MDG
    Aging Clin Exp Res; 2023 Aug; 35(8):1741-1752. PubMed ID: 37264166
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Shared Genetic Background Between Cerebrospinal Fluid Biomarkers and Risk for Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.
    Kim S; Kim K; Nho K; Myung W; Won HH
    J Alzheimers Dis; 2021; 80(3):1197-1207. PubMed ID: 33646147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.